BiotechTube

Olaparib Pill + AZD6738

Phase 2Completed
0 watching 0 views this week⚡ Active
52
Hype Score

Development Stage

✓
Pre-clinical
✓
Phase 1
3
Phase 2
4
Phase 3
5
Approved
Indication / Disease

High Grade Serous Carcinoma

Conditions

High Grade Serous Carcinoma

Trial Timeline

Mar 9, 2018 → Jul 21, 2025

NCT ID
NCT03462342

About Olaparib Pill + AZD6738

Olaparib Pill + AZD6738 is a phase 2 stage product being developed by AstraZeneca for High Grade Serous Carcinoma. The current trial status is completed. This product is registered under clinical trial identifier NCT03462342. Target conditions include High Grade Serous Carcinoma.

Hype Score Breakdown

Clinical
17
Activity
12
Company
10
Novelty
5
Community
5

Clinical Trials (1)

NCT IDPhaseStatus
NCT03462342Phase 2Completed

Competing Products

20 competing products in High Grade Serous Carcinoma

See all competitors
ProductCompanyStageHype Score
azenosertibZentalis PharmaceuticalsPhase 2
44
GTB-3550 TriKE® Phase I + GTB-3550 TriKE® Phase IIGT BiopharmaPhase 1/2
33
Sepantronium BromideCothera BiosciencePhase 2
44
Edoxaban + ASADaiichi SankyoPhase 3
77
olanzapine plus fosaprepitant-based triple regimen + placebo plus fosaprepitant-based triple regimenSun PharmaceuticalPhase 3
77
Bunazosin + Doxazosin + ValsartinEisaiApproved
85
Pembrolizumab + Pemetrexed + AbemaciclibEli LillyPhase 1
33
DSP-0390Sumitomo PharmaPhase 1
33
dalpiciclib isethionate tablets; abiraterone acetate tablets; prednisone tablets + placebo; abiraterone acetate tablets; prednisone tabletsJiangsu Hengrui MedicinePhase 1
33
SHR6390 + placeboJiangsu Hengrui MedicinePhase 3
77
SHR3680 + PlaceboJiangsu Hengrui MedicinePhase 3
77
Camrelizumab、Rivoceranib + CamrelizumabJiangsu Hengrui MedicinePhase 2
52
Mirvetuximab soravtansine + CarboplatinAbbViePhase 2
52
HHPG-19K InjectionJiangsu Hengrui MedicinePhase 3
77
Mirvetuximab SoravtansineAbbViePhase 2
52
Zibotentan/Dapagliflozin + DapagliflozinAstraZenecaPhase 2
52
AZD5718 IR tablet + AZD5718 oral suspension + Rosuvastatin tabletAstraZenecaPhase 1
33
Metoprolol Succinate + HydrochlorothiazideAstraZenecaPhase 3
77
DAPA/MET XR + DAPA + MET XRAstraZenecaPhase 3
77
Zibotentan/Dapagliflozin + DapagliflozinAstraZenecaPhase 3
77

Other Products from AstraZeneca

QuetiapineApproved
85
Dapagliflozin 5 mg + Placebo tabletApproved
85
QuetiapineApproved
85
Ticagrelor + ClopidogrelApproved
85
DurvalumabApproved
85